IRIS
DELLA TORRE, EMANUEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.555
NA - Nord America 2.190
EU - Europa 2.059
SA - Sud America 1.079
AF - Africa 75
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.997
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.074
SG - Singapore 1.317
CN - Cina 1.154
BR - Brasile 888
IT - Italia 768
SE - Svezia 514
HK - Hong Kong 497
VN - Vietnam 299
RU - Federazione Russa 191
DE - Germania 151
GB - Regno Unito 97
FI - Finlandia 91
AR - Argentina 69
CA - Canada 50
IN - India 46
MX - Messico 46
NL - Olanda 45
AT - Austria 37
ID - Indonesia 35
ZA - Sudafrica 33
BD - Bangladesh 32
ES - Italia 32
JP - Giappone 32
PL - Polonia 32
AU - Australia 30
EC - Ecuador 30
TR - Turchia 27
PY - Paraguay 24
FR - Francia 21
CO - Colombia 20
IQ - Iraq 19
IE - Irlanda 18
UA - Ucraina 17
PE - Perù 16
CL - Cile 14
PK - Pakistan 14
VE - Venezuela 13
TN - Tunisia 11
IR - Iran 10
EG - Egitto 9
IL - Israele 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
MA - Marocco 8
BE - Belgio 7
LT - Lituania 7
NZ - Nuova Zelanda 7
JO - Giordania 6
KE - Kenya 6
UZ - Uzbekistan 6
DZ - Algeria 5
HN - Honduras 5
KZ - Kazakistan 5
MY - Malesia 5
NP - Nepal 5
SA - Arabia Saudita 5
AL - Albania 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
PH - Filippine 4
PT - Portogallo 4
UY - Uruguay 4
BH - Bahrain 3
CY - Cipro 3
LB - Libano 3
LV - Lettonia 3
RO - Romania 3
TW - Taiwan 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EU - Europa 2
GR - Grecia 2
JM - Giamaica 2
KR - Corea 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
PA - Panama 1
SC - Seychelles 1
SI - Slovenia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 8.997
Salva come PNG Salva come JPEG
Città #
Singapore 555
Hong Kong 494
Dallas 442
Shanghai 310
Beijing 237
Ashburn 223
Hefei 199
Lawrence 183
Princeton 183
New York 160
Milan 137
Ho Chi Minh City 111
Moscow 107
São Paulo 83
Helsinki 75
Los Angeles 62
Hanoi 60
Rome 58
Boardman 52
Munich 45
Rio de Janeiro 33
Nuremberg 30
Denver 27
London 27
Warsaw 27
Belo Horizonte 23
Tokyo 23
Poplar 20
Seattle 20
Santa Clara 19
Brooklyn 18
Dublin 18
Turin 18
Cagliari 17
Guangzhou 17
Atlanta 16
Vienna 16
Orem 15
Phoenix 15
Brasília 14
Cesano Boscone 14
Johannesburg 14
Mexico City 14
Montreal 14
Toronto 14
Florence 13
Genoa 13
Haiphong 13
Manaus 13
Ankara 12
Boston 12
Chennai 12
Frankfurt am Main 12
Mapello 12
Quito 12
Stockholm 12
Bari 11
Houston 11
Porto Alegre 11
Turku 11
Bologna 10
Curitiba 10
Guarulhos 10
Pavia 10
Pescara 10
Rovigo 10
San Francisco 10
Wollongong 10
Xi'an 10
Amsterdam 9
Baghdad 9
Bergamo 9
Galliate 9
Jiaxing 9
Pune 9
Salvador 9
Asunción 8
Biên Hòa 8
Brisbane 8
Campinas 8
Cape Town 8
Da Nang 8
Falkenstein 8
Guayaquil 8
Jakarta 8
Naples 8
Sundbyberg 8
Vaprio d'Adda 8
Verona 8
Alessandria 7
Bauru 7
Borås 7
Breda 7
Calasparra 7
Caruaru 7
Caxias do Sul 7
Lima 7
Melbourne 7
Mugnano di Napoli 7
Reston 7
Totale 4.773
Salva come PNG Salva come JPEG
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 322
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 180
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 133
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 114
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 107
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 102
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 95
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 93
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 89
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 85
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 80
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 79
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 77
Advances in the diagnosis and management of IgG4 related disease. 75
IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. 73
Analisi delle sottopopolazioni T linfocitarie su sangue periferico dei pazienti affetti da malattia IgG4 correlata: aspetti patogenetici e risposta alla terapia con rituximab 73
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 72
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 71
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 69
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 69
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 67
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 67
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 65
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 64
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 64
IgG4-Related Midline Destructive Lesion: Expanding the spectrum of organ involvement in IgG4-related disease 64
ALLERGIC PROFILE AND ALLERGENSPECIFIC IMMUNOTHERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A SINGLE CENTER OBSERVATIONAL STUDY 63
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 62
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 62
B cells orchestrate tissue fibrosis in IgG4-Related Disease 62
ANTIAPOPTOTIC AND IMMUNOMODULATORY EFFECTS OF INTERLEUKIN 7 IN AN EX VIVO MODEL OF HUMAN LYMPHOID TISSUE 61
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 60
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 60
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 60
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 60
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 59
Urgent manifestations of immunoglobulin G4-related disease 59
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 59
Salivary Gland Disease in IgG4-Related Disease is Associated with Allergic Conditions 59
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 58
"How I manage" IgG4-Related Disease 58
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 57
Clinical and dermoscopic features of Castelman's disease: insights from an emblematic case 55
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang 54
Systemic lupus erythematosus and COVID-19: what we know so far 54
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 53
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 53
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 52
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 52
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 52
Artrite reumatoide. Dottore mi spieghi meglio 52
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 51
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 51
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 51
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 51
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 50
Malattia sistemica e colangiopatia IgG4-relata 50
25. Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study. 50
Atopia e malattia IgG4-correlata: relazione casuale o causale? 50
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 49
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 49
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 49
MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION 49
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 49
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 49
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 49
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 48
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 48
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 48
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 48
EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study 48
IgG4-Related diseases 48
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 45
Lymphadenopathy in the rheumatology practice: a pragmatic approach 45
Identification of Galectin-3 as an autoantigen in IgG4-Related Disease using monoclonal antibodies from dominantly expanded patient-derived plasmablasts 45
IDENTIFICATION OF GALECTIN-3 AS AN AUTO-ANTIGEN IN IGG4-RELATED DISEASE USING MONOCLONAL ANTIBODIES FROM DOMINANTLY EXPANDED PATIENT-DERIVED PLASMABLASTS 45
Clonal Expansion of a Speci c Subset of Cytotoxic CD4+T Cells and Tissue Apoptosis in Patients with IgG4-related Disease 45
IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. 45
Side effects from polydioxanone 45
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 44
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 44
EFFICACY OF LONG-TERM TREATMENT WITH BIOLOGIC AGENTS IN REFRACTORY ADULT ONSET STILL’S DISEASE: A SINGLE CENTRE EXPERIENCE ON 16 PATIENTS 44
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 44
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED AUTOIMMUNE PANCREATITIS 44
Cannabaceae pollen in the atmosphere of Brianza, Northen Italy 44
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 43
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 43
LA DEPLEZIONE DI CELLULE B RIDUCE IL GRADO DI FIBROSI SISTEMICA E L’ATTIVAZIONE DEI MIOFIBROBLASTI TISSUTALI IN CORSO DI MALATTIA IGG4-CORRELATA 43
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 43
Clonally Expanded CD4+ Cytotoxic T Cells, Endothelial Cell Apoptosis and the Pathogenesis of Early Systemic Sclerosis 42
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 42
IgG4-­RD Cases and Mimickers: A Summary 42
CLONAL EXPANSION OF CD4+ CYTOTOXIC T LYMPHOCYTES IN IGG4-RELATED DISEASE 41
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 41
Circulating TH2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy 41
B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. 41
Optimal management of DRESS syndrome in course of infectious endocarditis. 41
Malattie autoinfiammatorie e altre malattie immunomediate a patogenesi incerta 41
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 40
Totale 6.178
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.477
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 8 4 1 1 1 3 1
2021/2022348 1 0 151 33 6 22 14 23 34 21 23 20
2022/20231.129 455 213 66 8 32 115 62 57 59 14 22 26
2023/2024920 30 62 81 82 49 167 42 89 5 42 92 179
2024/20252.858 351 84 81 76 97 222 352 300 550 329 177 239
2025/20263.957 631 790 689 1.061 631 155 0 0 0 0 0 0
Totale 9.261